Copart buys ACV for $1.9B, but EPS accretion waits until FY2028

The deal confirms a transaction the market had already begun to anticipate. Media reports had already circulated regarding a potential ACV transaction, and Copart’s offer references August 10, 2026 as the last trading day before those reports; the announcement therefore adds firm terms and board approval more than a completely unexpected strategic direction. (Transaction Details) 〔0〕

Copart is paying $1.9 billion in cash to enter dealer-to-dealer wholesale remarketing. ACV adds a digital marketplace, dealer relationships, inspection technology, vehicle-condition data, and AI-powered valuation tools that complement Copart’s physical auction network and buyer base. (Strategic and Financial Benefits) 〔1〕

The financial payoff is back-end loaded rather than immediate. Copart expects the transaction to be neutral to EPS in the first full year of ownership and accretive beginning in fiscal 2028, so the announcement does not improve near-term earnings expectations; investors must underwrite the strategic growth and synergy case before receiving a reported earnings benefit. (Strategic and Financial Benefits) 〔2〕

The balance-sheet risk is manageable, but execution risk remains material. Copart says it will fund the purchase with cash on hand and that no financing condition applies, while closing still depends on majority shareholder tender, antitrust review, and other customary conditions. (Transaction Details) 〔3〕

Net read: strategically constructive, but not a clean near-term earnings beat. Relative to the partially anticipated deal, the key new information is the $10.50 cash price, the lack of immediate EPS accretion, and the targeted calendar-year 2026 close. That combination supports a mixed read: Copart gains a meaningful adjacent growth platform, but the filing offers no immediate earnings uplift and leaves synergy delivery and regulatory approval to prove the value.